Skip to search.
 NZX 50 Up 0.34%

Keryx Biopharmaceuticals, Inc. (KERX)

-NasdaqCM
4.89 Down 0.34(6.41%) 10:00
|After Hours : 4.90 Up 0.00 (0.01%) 10:51 - Nasdaq Real Time Price
Prev Close:5.23
Open:5.22
Bid:4.79 x 500
Ask:5.09 x 2000
1y Target Est:7.21
Beta:3.18485
Earnings Date:23 Feb - 27 Feb (Est.)
Day's Range:4.76 - 5.25
52wk Range:3.11 - 7.80
Volume:2,905,987
Avg Vol (3m):1,509,150
Market Cap:518.67m
P/E (ttm):N/A
EPS (ttm):-1.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXDown 6.41%518.67m
BAXDown 0.37%24.94b
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.45
Quarterly EPS Est (Dec-16) :-0.25
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback